Back to AXSM
Invesco Ltd. AXSM Position History
Axsome Therapeutics, Inc. • Healthcare
Quarters held
42
Latest value
$1.9M
Q3 2026
Peak value
$364.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $3M |
| Q4 2025 | $208.7M |
| Q4 2025 | $1.1M |
| Q4 2025 | $8K |
| Q4 2025 | $915K |
| Q4 2025 | $2.6M |
| Q4 2025 | $74K |
| Q4 2025 | $10M |
| Q4 2025 | $4.8M |
| Q4 2025 | $1.4M |
| Q1 2026 | $2.8M |
| Q1 2026 | $200.3M |
| Q1 2026 | $1M |
| Q1 2026 | $11K |
| Q1 2026 | $872K |
| Q1 2026 | $2.4M |
| Q1 2026 | $68K |
| Q1 2026 | $6.2M |
| Q1 2026 | $4.4M |
| Q1 2026 | $1.3M |
| Q2 2026 | $4.3M |
| Q2 2026 | $364.7M |
| Q2 2026 | $435K |
| Q2 2026 | $2.4M |
| Q2 2026 | $28K |
| Q2 2026 | $1.6M |
| Q2 2026 | $4.6M |
| Q2 2026 | $111K |
| Q2 2026 | $19.1M |
| Q2 2026 | $9.4M |
| Q2 2026 | $2.5M |
| Q3 2026 | $2.7M |
| Q3 2026 | $334.5M |
| Q3 2026 | $921K |
| Q3 2026 | $1.6M |
| Q3 2026 | $27K |
| Q3 2026 | $1.3M |
| Q3 2026 | $3.4M |
| Q3 2026 | $82K |
| Q3 2026 | $2.1M |
| Q3 2026 | $7.3M |
| Q3 2026 | $1.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.9M | 10.3K | — | — |
| Q3 2026 | $7.3M | 39.5K | — | — |
| Q3 2026 | $2.1M | 11.6K | — | — |
| Q3 2026 | $82K | 444 | — | — |
| Q3 2026 | $3.4M | 18.6K | — | — |
| Q3 2026 | $1.3M | 7.3K | — | — |
| Q3 2026 | $27K | 144 | — | — |
| Q3 2026 | $1.6M | 8.9K | — | — |
| Q3 2026 | $921K | 5.0K | — | — |
| Q3 2026 | $334.5M | 1.81M | — | — |
| Q3 2026 | $2.7M | 14.8K | — | — |
| Q2 2026 | $2.5M | 10.4K | — | — |
| Q2 2026 | $9.4M | 38.2K | — | — |
| Q2 2026 | $19.1M | 78.0K | — | — |
| Q2 2026 | $111K | 454 | — | — |
| Q2 2026 | $4.6M | 18.7K | — | — |
| Q2 2026 | $1.6M | 6.7K | — | — |
| Q2 2026 | $28K | 115 | — | — |
| Q2 2026 | $2.4M | 9.7K | — | — |
| Q2 2026 | $435K | 1.8K | — | — |
| Q2 2026 | $364.7M | 1.49M | — | — |
| Q2 2026 | $4.3M | 17.6K | — | — |
| Q1 2026 | $1.3M | 7.6K | — | — |
| Q1 2026 | $4.4M | 26.2K | — | — |
| Q1 2026 | $6.2M | 36.5K | — | — |
| Q1 2026 | $68K | 403 | — | — |
| Q1 2026 | $2.4M | 14.0K | — | — |
| Q1 2026 | $872K | 5.2K | — | — |
| Q1 2026 | $11K | 65 | — | — |
| Q1 2026 | $1M | 6.1K | — | — |
| Q1 2026 | $200.3M | 1.18M | — | — |
| Q1 2026 | $2.8M | 16.7K | — | — |
| Q4 2025 | $1.4M | 7.9K | — | — |
| Q4 2025 | $4.8M | 26.2K | — | — |
| Q4 2025 | $10M | 54.5K | — | — |
| Q4 2025 | $74K | 403 | — | — |
| Q4 2025 | $2.6M | 14.0K | — | — |
| Q4 2025 | $915K | 5.0K | — | — |
| Q4 2025 | $8K | 42 | — | — |
| Q4 2025 | $1.1M | 6.1K | — | — |
| Q4 2025 | $208.7M | 1.14M | — | — |
| Q4 2025 | $3M | 16.6K | — | — |
Other funds holding AXSM
$697.4M
$467.7M
$442.1M
$402.1M